News
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support ...
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...
Together with Bio-Rad’s existing line of QX200™ and QX600™ ddPCR systems, the expanded product portfolio, including over 400,000 assays, offers the most comprehensive line of digital PCR ...
Bio-Rad Laboratories has announced the new Bio-Rad CFX96™ real-time PCR detection system. The CFX96 optical reaction module builds on the flexibility of the C1000 thermal cycler, creating a real-time ...
HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO and BIO.B), a life sciences company with a market capitalization of $6.8 billion and strong financial health according to InvestingPro data, ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...
The CFX Duet System offers the robust thermal performance and proprietary, accurate optical shuttle system of Bio-Rad’s CFX Opus System, with thermal gradient functionality to enable optimization in ...
Introducing our In Focus on the evolution of PCR, this video explores the well-established technique, particularly in context of the COVID-19 pandemic. Discover the limitations of qPCR, how droplet ...
The app is divided into four sections: qPCR guide, PCR doctor, PCR reagents selectors, and assay design. While one will certainly encounter plugs for Bio-Rad products, these product placements are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results